Home › Funds › Bain Capital Life Sciences Investors, LLC › NAMSW

Bain Capital Life Sciences Investors, LLC position in NAMSW

NEWAMSTERDAM PHARMA COMPANY · Materials

Bain Capital Life Sciences Investors, LLC reported holding 99,999 shares of NAMSW (NEWAMSTERDAM PHARMA COMPANY) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.09% of its reported portfolio and ranking #22 among its reported holdings. Bain Capital Life Sciences Investors, LLC has disclosed NAMSW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)100.00K sh
Reported value held$1.26M
Portfolio Weight0.09%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Bain Capital Life Sciences Investors, LLC's NAMSW position evolved

Bain Capital Life Sciences Investors, LLC first disclosed a stake in NAMSW in Q3 2023 at 100,000 shares (US$190K). The position peaked in Q4 2025 at 99,999 shares, worth US$2.3M. Across 13 filings, Bain Capital Life Sciences Investors, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 99,999 shares valued at US$1.3M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 100.00K $190.00K New
Q4 2023 100.00K $313.00K Hold
Q1 2024 100.00K $1.10M Hold
Q2 2024 100.00K $872.00K Hold
Q3 2024 100.00K $700.00K Hold
Q4 2024 100.00K $1.43M Hold
Q1 2025 100.00K $899.00K Hold
Q2 2025 100.00K $800.00K Hold
Q3 2025 100.00K $1.71M Hold
Q4 2025 100.00K $2.30M Hold
Q1 2026 100.00K $2.00M Hold
Q2 2026 100.00K $2.14M Hold
Q3 2026 100.00K $1.26M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NAMSW and 13F data

NAMSW (NEWAMSTERDAM PHARMA COMPANY) is a Materials company. 10 other funds we track also report a position in NAMSW — the largest reported positions include Frazier Life Sciences Management, L.P. (US$10.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NAMSW

All NAMSW fund holders →

FAQ

How long has Bain Capital Life Sciences Investors, LLC held NAMSW?

Bain Capital Life Sciences Investors, LLC has disclosed NAMSW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Bain Capital Life Sciences Investors, LLC's current position in NAMSW?

As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 100.00K shares of NAMSW (NEWAMSTERDAM PHARMA COMPANY), valued at $1.26M, representing 0.09% of its reported portfolio and ranking #22.

Has Bain Capital Life Sciences Investors, LLC been buying or selling NAMSW?

In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC held unchanged its position in NAMSW. The position peaked in Q4 2025 at 100.00K shares.

Which other funds hold NAMSW?

Other major institutional holders of NAMSW include Frazier Life Sciences Management, L.P., among 10 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.